Charles River Laboratories | CRL - EPS Earnings Per Share


Charles River Laboratories reported $3.09 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 3.09 3.05 2.43 Nov/04
FY2026Q2 Jun/2026 3.02 2.74 3.12 Aug/05
FY2026Q1 Mar/2026 2.06 1.93 2.34 May/07
FY2025Q4 Dec/2025 2.39 2.35 2.66 Feb/18
FY2025Q3 Sep/2025 2.43 2.34 2.59 Nov/05




Eps Change Date
Agilent USD 1.52 0.08 Jun/2026
Align Technology USD 2.8 0.16 Sep/2026
Bio-Rad Laboratories USD 2.65 0.03 Sep/2026
Bruker USD 0.56 0.07 Sep/2026
Cardinal Health USD 2.65 0.05 Sep/2026
Charles River Laboratories USD 3.09 0.07 Sep/2026
Cigna USD 7.98 0.2 Sep/2026
Concord Medical Services Hldg CNY -0.33 0.12 Dec/2025
CVS Health USD 2.09 0.49 Sep/2026
Danaher USD 1.75 0.19 Sep/2026
Dentsply International USD 0.29 0.23 Sep/2026
Elevance Health USD 6.27 1.18 Sep/2026
Humana USD -0.7 8.31 Sep/2026
Illumina USD 1.44 0.13 Sep/2026
Incyte USD -3.6 6.69 Sep/2026
Intrexon USD -0.1 0.03 Jun/2024
IQVIA Holdings USD 3.34 0.19 Sep/2026
Laboratory Of America USD 4.78 0.21 Sep/2026
Lakefront Biotherapeutics EUR -0.23 0.03 Sep/2026
Lonza CHF 6.07 1.92 Jun/2025
McKesson USD 11.15 1.22 Sep/2026
Merck EUR -0.54 2.65 Jun/2026
Mettler Toledo International USD 12.57 1.11 Sep/2026
Novartis USD 2.46 0.05 Sep/2026
Pfizer USD 0.87 0.1 Sep/2026
Quest Diagnostics USD 2.79 0.33 Sep/2026
Revvity USD 1.37 0.04 Sep/2026
Thermo Fisher Scientific USD 5.18 0.86 Sep/2026
United Therapeutics USD 5.71 1.56 Sep/2026
UnitedHealth USD 4.39 1.98 Sep/2026
Veradigm USD -0.34 0.46 Dec/2022
Waters USD 4.1 1.05 Sep/2026
West Pharmaceutical Services USD 2.66 0.29 Sep/2026